Moderna Inc (MRNA) — Capital Reinvestment Ratio
Moderna Inc (MRNA) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow ($951.00 Million) in capital expenditures ($39.00 Million). See MRNA equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Moderna Inc Capital Reinvestment Ratio (2016–2022)
This chart tracks Moderna Inc's Capital Reinvestment Ratio across 4 annual periods. Check MRNA cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Moderna Inc (2016–2022)
Year-by-year Capital Reinvestment Ratio for Moderna Inc from 2016 to 2022. For live market cap and broader valuation context, see market value of Moderna Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.08x | $4.98 Billion | $400.00 Million | ▲ +285.1% |
| 2021 | 0.02x | $13.62 Billion | $284.00 Million | ▼ -37.3% |
| 2020 | 0.03x | $2.03 Billion | $67.45 Million | ▼ -93.3% |
| 2016 | 0.50x | $66.73 Million | $33.14 Million | — |